Xilio Development, Inc.
4 clinical trials · Sponsor
◉ Watch Xilio Development, Inc.
| Record | Firm | Date |
|---|---|---|
| XTX501 in Patients With Metastatic Non-Small Cell Lung Cancer and Advanced Solid Tumors (NCT07688577) | Xilio Development, Inc. | 2026-08-01 |
| XTX301 in Patients With Advanced Solid Tumors (NCT05684965) | Xilio Development, Inc. | 2023-05-11 |
| Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid Tumors (NCT04896697) | Xilio Development, Inc. | 2021-09-13 |
Track Xilio Development, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.